Parkinson's disease and health economics: cost-effectiveness in incident PD

被引:0
|
作者
Vossius, C. [1 ,2 ,3 ]
Nilsen, O. B. [2 ,4 ]
Larsen, J. P. [1 ,2 ,5 ]
机构
[1] Stavanger Univ Hosp, Dept Neurol, Stavanger, Norway
[2] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway
[3] Stokka Teaching Nursing Home, Stavanger, Norway
[4] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway
[5] Univ Bergen, Inst Med, Bergen, Norway
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:523 / 523
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of pramipexole in early Parkinson's disease
    Noyes, K
    Dick, AW
    Holloway, RG
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 274 - 274
  • [2] Cost-effectiveness of pramipexole in Parkinson's disease in the United States
    Hoerger, TJ
    Bala, MV
    Rowland, C
    Greer, M
    Holloway, R
    [J]. NEUROLOGY, 1998, 50 (04) : A298 - A299
  • [3] Cost-effectiveness analysis of spa therapy in Parkinson's disease
    Brefel-Courbon, C
    Desboeuf, K
    Thalamas, C
    Galitzky, M
    Senard, JM
    Rascol, O
    [J]. MOVEMENT DISORDERS, 2002, 17 : S73 - S73
  • [4] Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cost-effectiveness studies
    Wimo, Anders
    Norlund, Anders
    [J]. ALZHEIMERS & DEMENTIA, 2007, 3 (03) : 157 - 161
  • [5] Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's Disease
    Verschuur, Constant V. M.
    Suwijn, Sven R.
    de Haan, Rob J.
    Boel, Judith A.
    Post, Bart
    Bloem, Bas R.
    van Hilten, Johannes J.
    van Laar, Teus
    Tissingh, Gerrit
    Munts, Alexander
    Dijkgraaf, Marcel G. W.
    de Bie, Rob M. A.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2022, 12 (07) : 2171 - 2178
  • [6] COST-EFFECTIVENESS ANALYSIS OF A HYPOTHETICAL DISEASE MODIFYING THERAPY FOR PARKINSON'S DISEASE
    Chandler, C.
    Gal, P.
    Folse, H.
    Chavan, A.
    Ward, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S633 - S633
  • [7] Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease
    Chaudhuri, K. Ray
    Hand, Annette
    Obam, Fallon
    Belsey, Jonathan
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 774 - 782
  • [8] Cost-effectiveness analysis in Parkinson's disease: Determining the value of interventions
    Siderowf, AD
    Holloway, RG
    Stern, MB
    [J]. MOVEMENT DISORDERS, 2000, 15 (03) : 439 - 445
  • [9] Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications
    Dams, Judith
    Balzer-Geldsetzer, Monika
    Siebert, Uwe
    Deuschl, Guenther
    Schuepbach, W. M. Michael
    Krack, Paul
    Timmermann, Lars
    Schnitzler, Alfons
    Reese, Jens-Peter
    Dodel, Richard
    [J]. MOVEMENT DISORDERS, 2016, 31 (08) : 1183 - 1191
  • [10] THE COST-EFFECTIVENESS OF DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE PATIENTS
    Dams, J.
    Siebert, U.
    Bornschein, B.
    Volkmann, J.
    Deuschl, G.
    Oertel, W. H.
    Reese, J. P.
    Dodel, R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A368 - A368